10Oct/13

From 2012 to 2022, the Rheumatoid Arthritis Market Will Grow Moderately … – The Providence Journal

From 2012 to 2022, the Rheumatoid Arthritis Market Will Grow Moderately
The Providence Journal
Pfizer/Takeda’s Jak inhibitor Xeljanz will likely be used after the TNF-alpha inhibitors initially, competing with Bristol-Myers Squibb/Ono Pharmaceutical’s Orencia, rituximab (Biogen Idec/Roche/Chugai/Zenyaku Kogyo’s Rituxan, Roche’s MabThera) and 

and more »

10Oct/13

'Every heart in India is crying today': India mourns the retirement of Sachin … – The Independent


The Independent

‘Every heart in India is crying today’: India mourns the retirement of Sachin
The Independent
“Every heart in India is crying today. Cricket is over.” On social media, cricket fan and government minister Shashi Tharoor declared that Tendulkar had been the “greatest Indian to wield a bat”. “He has given us all so much,” he added of the man with
Sachin Tendulkar to retire after 200th test, says ‘heart feels it’s time.’NDTV
Sachin Tendulkar to retire after 200th, says heart feels it’s time!Indian Express
Tendulkar to quit after 200th testReuters India
Cricket Country –The Guardian
all 353 news articles »
10Oct/13

Cardiac Biomarker ST2 Helps Assess Heart Failure Risk And Identify Heart … – EON: Enhanced Online News (press release)

Cardiac Biomarker ST2 Helps Assess Heart Failure Risk And Identify Heart
EON: Enhanced Online News (press release)
SAN DIEGO–(BUSINESS WIRE)–Critical Diagnostics announced today that results of the HF-ACTION study just published in the American Heart Association’s Circulation: Heart Failure demonstrate that levels of the biomarker ST2 are predictive of long-term